Signal Advisors Wealth, LLC Bristol Myers Squibb CO Transaction History
Signal Advisors Wealth, LLC
- $1.1 Trillion
- Q3 2025
A detailed history of Signal Advisors Wealth, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Signal Advisors Wealth, LLC holds 11,981 shares of BMY stock, worth $560,830. This represents 0.05% of its overall portfolio holdings.
Number of Shares
11,981
Previous 29,158
58.91%
Holding current value
$560,830
Previous $1.35 Billion
59.97%
% of portfolio
0.05%
Previous 0.11%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,681Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...